Kbc Group Nv Corcept Therapeutics Inc Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Kbc Group Nv holds 2,822 shares of CORT stock, worth $143,526. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,822

Previous 2,326 21.32%

Holding current value

$143,526

Previous $76,000 72.37%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$29.51 - $46.26 $14,636 - $22,944	496 Added 21.32%	2,822 $131,000
Q4 2023 Feb 13, 2024	SELL	$24.82 - $32.88 $118,664 - $157,199	-4,781 Reduced 67.27%	2,326 $76,000
Q3 2023 Feb 15, 2024	SELL	$21.97 - $33.8 $98,777 - $151,964	-4,496 Reduced 63.26%	2,611 $71,000
Q2 2023 Feb 15, 2024	SELL	$21.44 - $25.15 $29,437 - $34,530	-1,373 Reduced 16.19%	7,107 $158,000
Q2 2023 Jul 28, 2023	SELL	$21.44 - $25.15 $14,107 - $16,548	-658 Reduced 8.47%	7,107 $158,000
Q1 2023 Feb 14, 2024	SELL	$19.2 - $24.47 $13,728 - $17,496	-715 Reduced 8.43%	7,765 $168,000
Q1 2023 May 04, 2023	SELL	$19.2 - $24.47 $13,728 - $17,496	-715 Reduced 8.43%	7,765 $168,000
Q3 2022 Feb 15, 2024	BUY	$24.7 - $29.12 $152,003 - $179,204	6,154 Added 264.57%	8,480 $217,000
Q2 2022 Feb 14, 2024	SELL	$17.33 - $25.3 $24,261 - $35,420	-1,400 Reduced 14.17%	8,480 $202,000
Q2 2022 Jul 26, 2022	SELL	$17.33 - $25.3 $24,261 - $35,420	-1,400 Reduced 14.17%	8,480 $202,000
Q4 2021 Feb 14, 2024	BUY	$17.1 - $23.34 $129,173 - $176,310	7,554 Added 324.76%	9,880 $196,000
Q4 2021 Feb 03, 2022	SELL	$17.1 - $23.34 $65,629 - $89,578	-3,838 Reduced 27.98%	9,880 $196,000
Q4 2020 Feb 10, 2021	SELL	$16.78 - $27.3 $57,521 - $93,584	-3,428 Reduced 19.99%	13,718 $359,000
Q1 2020 May 04, 2020	SELL	$10.11 - $14.04 $316,908 - $440,097	-31,346 Reduced 64.64%	17,146 $204,000
Q1 2019 May 10, 2019	SELL	$10.03 - $15.71 $2.61 Million - $4.08 Million	-259,982 Reduced 84.28%	48,492 $0
Q3 2018 Nov 14, 2018	SELL	$12.27 - $15.65 $744,371 - $949,422	-60,666 Reduced 16.43%	308,474 $0
Q2 2018 Aug 03, 2018	BUY	$15.3 - $19.69 $5.65 Million - $7.27 Million	369,140 New	369,140 $0

Others Institutions Holding CORT

# of Institutions

346

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.45B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account